HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sensitization of P388 murine leukemia cells to hydroxyurea cytotoxicity by hydrophobic iron-chelating agents.

Abstract
The potentiation in the cytotoxic effect of antineoplastic agent hydroxyurea (HU) from the non-toxic concentration on P388 murine lymphocytic leukemia cells is observed with the hydrophobic iron-chelating agents, 2,2-bipyridine (bipyridyl) and 1,10-phenanthroline in a concentration and time dependent manner. However EDTA, EGTA, 2,3-dihydroxybenzoic acid (2,3-DBA), Rhodotorulic acid, 8-hydroxyquinoline (8-Hq), catechin and Desferal, and other chelators failed to show sensitization of these tumor cells towards HU. The potentiation in the cytotoxic activity of HU in combination with the bipyridyl was found to be reversible but was maintained when the drug exposed cells were washed and retreated with the non-toxic concentrations of HU or bipyridyl. The presence of Fe++ blocked completely the cytotoxic action of HU alone and a combination with iron-chelator, and partially reversed the inhibition induced by HU and bipyridyl. These findings suggest that the hydrophobic iron-chelators affect the membrane-mediated transfer, localisation and transient intracellular chelatable iron pools. As a consequence of this, the regulatory role mediated by iron on the overall activity of ribonucleotide reductase enzyme is disturbed leading to a conclusive imbalance in DNA biosynthesis.
AuthorsK Satyamoorthy, M Chitnis, V Basrur
JournalAnticancer research (Anticancer Res) 1986 Mar-Apr Vol. 6 Issue 2 Pg. 329-33 ISSN: 0250-7005 [Print] Greece
PMID3518597 (Publication Type: Journal Article)
Chemical References
  • Iron Chelating Agents
  • Tritium
  • 2,2'-Dipyridyl
  • DNA
  • Iron
  • Ribonucleotide Reductases
  • Thymidine
  • Hydroxyurea
Topics
  • 2,2'-Dipyridyl (pharmacology)
  • Animals
  • DNA (biosynthesis)
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Hydroxyurea (pharmacology)
  • Iron (metabolism)
  • Iron Chelating Agents (pharmacology)
  • Leukemia P388 (drug therapy, metabolism)
  • Leukemia, Experimental (metabolism)
  • Mice
  • Mice, Inbred DBA
  • Ribonucleotide Reductases (antagonists & inhibitors)
  • Thymidine (metabolism)
  • Tritium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: